1
03月
Qidu Pharmaceutical large particle sodium bicarbonate preparation technology won the national invention patentOn February 9, Shandong Qidu Pharmaceutical Co., Ltd. and Tianjin University jointly declared the "preparation method and device of large particle sodium bicarbonate" authorized by the national invent
10
01月
Qidu Pharmaceutical Group 2023 ten major events announced1. Infusion output of Qidu Pharmaceutical's main product reached a record high of 1.36 billion bottles.In 2023, the production workshops of Qidu Pharmaceutical will produce safely and stably at full c
10
11月
Qidu Pharma’s Launch of the First Home-made Levofloxacin Sodium Chloride InjectionThe Levofloxacin Sodium Chloride Injection independently researched and developed by Qidu Pharma is the first in China to be approved for marketing.Its drug approval number is H20203476 and H20203477.
18
08月
Moxifloxacin hydrochloride and sodium chloride injection has been approved for marketingOn May 8, 2019, moxifloxacin hydrochloride and sodium chloride injection, the latest generation of quinolones antibacterial drug, independently researched and developed by Qidu Pharmaceutical Co., Ltd
18
08月
Qidu Pharma’s Workshop of PP Ampoule Successful Passing GMP On-site InspectionFrom 25 to 28 December 2019, workshop 801 in Qidu Pharma, which produces PP ampoule, was under on-site inspection from GMP experts of Shandong Drug Administration.